The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis
Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.
Roots Analysis has announced the
addition of “Peptides
and Macrocycle Drug Discovery: Services and Platforms
Market, 2020-2030” report to its list of offerings.
The
report features an extensive study on the current market landscape and future
of companies offering services for peptides and macrocycle drug
discovery operations. The study includes in-depth analyses, highlighting the
capabilities of various service / technology providers engaged in this market.
Amongst other elements, the report includes:
§
A detailed assessment of the current market landscape of
companies offering peptide and macrocycle drug discovery services
§
An insightful geographical benchmarking of the capabilities
of companies of various sizes, highlighting the key focus areas, comparing
their existing strengths both within and beyond their respective peer groups
(based on geography and company size).
§
An in-depth analysis of peptide platform and library
service providers, featuring information on their company details, purpose of
the platform, type of peptide manufactured and platform access model.
§
Profiles of peptides and macrocycle drug discovery service
providers, featuring information on the year of establishment, location of
headquarters, peptide discovery service / platform portfolio, recent
developments, and an informed future outlook.
§
An analysis of the partnerships that have been established
in the recent past, covering mergers and acquisitions, research collaborations,
R&D agreements, licensing agreements (related to both technology platforms
and service providers) and other form of collaborations.
§
An analysis of proprietary display technologies developed
by different drug discovery technology providers, based on the 2X2 matrix.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§ Type of peptides
§ Synthetic
peptides
§ Biologic
and recombinant peptides
§ Type
of discovery steps
§
Target identification and validation
§
Hit identification
§
Lead generation
§
Lead optimization
§ Therapeutic
Area
§
Oncological disorders
§
Metabolic disorders
§
Cardiovascular disorders
§
Infectious diseases
§
Urological disorders
§
Endocrine disorders
§
CNS disorders
§
Other diseases
§ Company
Size
§
Small companies
§
Mid-sized companies
§
Large and very large companies
§ Key
geographical regions
§ Europe
§ North
America
§ Asia-Pacific
and the Rest of the World
Key
companies covered in the report
§ GenScript
§ JPT
Peptide Technologies
§ CPC
Scientific
§ IRBM
§ Creative
Peptides
§ Pepscan
§ Interprotein
§ RA
Pharmaceuticals
§ Pepticom
§ PeptiDream
§ Creative
Biolabs
§ MeSCue-Janusys
For
more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings
1.
DNA-Encoded Libraries: Platforms and Services
Market, 2020–2030
2.
Antibody Contract
Manufacturing
Market, 2020 – 2030
3.
Global Autoinjectors
Market,
2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment